Clinical Observation of Chemoradiotherapy Combined with Thermotherapy in the Treatment of Middle and Advanced Esophageal Cancer
10.6039/j.issn.1001-0408.2015.32.34
- VernacularTitle:放化疗联合热疗用于中晚期食管癌的临床观察
- Author:
Xiuyong LIAO
;
Fei LI
;
Yuping RAN
;
Enqiang LIU
- Publication Type:Journal Article
- Keywords:
Middle and advanced esophageal cancer;
Nedaplatin;
Radiotherapy;
Chemotherapy;
Thermotherapy
- From:
China Pharmacy
2015;(32):4560-4561,4562
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe short-term efficacy and ADR of nedaplatin concurrent chemoradiotherapy combined with thermotherapy in the treatment of middle and advanced esophageal cancer. METHODS:64 patients with middle and advanced esophageal cancer were randomly divided into control group and treatment group,with 32 cases in each group. Control group was given nedaplatin concurrent chemoradiotherapy,nedaplatin 30 mg/m2,ivgtt,every week during chemotherapy;treatment group re-ceived thermotherapy by high frequency heating machine before chemoradiotherapy,60 min/time,twice a week;received chemora-diotherapy 30 min after thermotherapy. Short-term efficacy and ADR were observed in 2 groups. RESULTS:The short-term total effective rate of treatment group(84.4%)was higher than that of control group(62.5%),with statistical significance(P<0.05). The incidence of bone marrow suppression,radioactive esophagitis and gastrointestinal reactions in treatment group vs. control group were(21.9%)vs.(46.9%),(18.8%)vs.(56.3%),(31.3%)vs.(59.4%),with statistical significance(P<0.05). CONCLU-SIONS:Nedaplatin concurrent chemoradiotherapy combined with thermotherapy is better than concurrent chemoradiotherapy in the treatment of middle and advanced esophageal cancer with low incidence of ADR.
